Preventive and therapeutic strategies for bovine leukemia virus: Lessons for HTLV

Viruses

Volumn 3, Issue 7, 2011, Pages 1210-1248

  Rodríguez, Sabrina M ^a   Florins, Arnaud ^a   Gillet, Nicolas ^a   de Brogniez, Alix ^a   Sánchez Alcaraz, María Teresa ^a   Boxus, Mathieu ^a   Boulanger, Fanny ^a   Gutiérrez, Gerónimo ^b   Trono, Karina ^b   Alvarez, Irene ^b   Vagnoni, Lucas ^b   Willems, Luc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

BLV; Control; Epigenetic; Eradication; Therapeutics; Vaccines

Indexed keywords

ALPHA INTERFERON; BOVINE LEUKEMIA VIRUS VACCINE; DNA VACCINE; INACTIVATED VIRUS VACCINE; INTERFERON; LIVE VACCINE; PEGINTERFERON ALPHA; PEPTIDE VACCINE; UNCLASSIFIED DRUG; VALPROIC ACID; VIRUS ANTIBODY; ZIDOVUDINE;

BIOSAFETY; BLOOD TRANSFUSION; BOVINE LEUKEMIA VIRUS; BREAST FEEDING; CATTLE FARMING; DISINFECTION; DNA METHYLATION; ENZOOTIC BOVINE LEUKOSIS; GENE THERAPY; HISTONE ACETYLATION; HOST RESISTANCE; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IATROGENIC DISEASE; IMMUNIZATION; INFECTION CONTROL; INFECTION RATE; LEUKOCYTE COUNT; NONHUMAN; POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; REVIEW; SEROPREVALENCE; SEXUAL TRANSMISSION; T CELL LEUKEMIA; TROPICAL SPASTIC PARAPARESIS; VETERINARY MEDICINE; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; CARRIER STATE; CATTLE; ENZOOTIC BOVINE LEUKOSIS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA VIRUS, BOVINE;

ANIMALIA; BOS; BOVINE LEUKEMIA VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79960823855     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3071210     Document Type: Review

References (331)

1. Leisering, A. Hypertrophy der Malpighischen Körperoen der Milz. Berl. Vet. West. Kgr. Sachsen 1871, 16, 15-16.
2. Olson, C.; Miller, J. History and terminology of enzootic bovine leukosis. In Enzootic Bovine Leukosis and Bovine Leukemia Virus; Burny, A., Mammerickx, M., Eds.; Martinus Nijhoff Publishing: Boston, MA, USA, 1987; pp. 3-14.
3. Bollinger, O. Über Leukämie bei den Haustieren. Virchows Arch. 1874, 59, 341-349.
4. Siedamgrotzky, O.; Hofmeister, V. Anleitung zur mikroskopischen und chemischen Diagnostik der Krankheiten der Hausthiere: für Thierärzte und Landwirthe/bearb. Schönfeld VIII: Dresden, Germany, 1876; p. 192.
5. Schöttler, F.; Schöttler, H. Über Ätiologie und Therapie der Aleukämischen Lymphadenose des Rindes. Berl. Muench. Tierarztl. Wochenschr. 1934, 50, 497-502, 513-517.
6. Johnson, R.; Kaneene, J.B. Bovine leukaemia virus and enzootic bovine leukosis. Vet. Bull. 1992, 62, 287-312.
7. Bendixen, H.J. Bovine enzootic leukosis. Adv. Vet. Sci. 1965, 10, 129-204.
8. Miller, J.M.; Miller, L.D.; Olson, C.; Gillette, K.G. Virus-like particles in phytohemagglutininstimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Natl. Cancer Inst. 1969, 43, 1297-1305.
9. Ferrer, J.F.; Marshak, R.R.; Abt, D.A.; Kenyon, S.J. Persistent lymphocytosis in cattle: Its cause, nature and relation to lymphosarcoma. Ann. Rech. Vet. 1978, 9, 851-857.
10. Ferrer, J.F. Bovine lymphosarcoma. Adv. Vet. Sci. Comp. Med. 1980, 24, 1-68.
11. Burny, A.; Bex, F.; Chantrenne, H.; Cleuter, Y.; Dekegel, D.; Ghysdael, J.; Kettmann, R.; Leclercq, M.; Leunen, J.; Mammerickx, M., et al. Bovine leukemia virus involvement in enzootic bovine leukosis. Adv. Cancer Res. 1978, 28, 251-311.
12. Burny, A.; Bruck, C.; Chantrenne, H.; Cleuter, Y.; Dekegel, D.; Ghysdael, J.; Kettmann, R.; Leclercq, M.; Leunen, J.; Mammerickx, M., et al. Bovine leukemia virus: Molecular biology and epidemiology. In Viral Oncology; Klein, G., Ed.; Raven Press: New York, NY, USA, 1980.
13. Burny, A.; Bruck, C.; Cleuter, Y.; Couez, D.; Deschamps, J.; Gregoire, D.; Ghysdael, J.; Kettmann, R.; Mammerickx, M.; Marbaix, G., et al. Bovine leukaemia virus and enzootic bovine leukosis. Onderstepoort J. Vet. Res. 1985, 52, 133-144.
14. Burny, A.; Cleuter, Y.; Kettmann, R.; Mammerickx, M.; Marbaix, G.; Portetelle, D.; van den Broeke, A.; Willems, L.; Thomas, R. Bovine leukaemia: Facts and hypotheses derived from the study of an infectious cancer. Vet. Microbiol. 1988, 17, 197-218.
15. Kettmann, R.; Portetelle, D.; Mammerickx, M.; Cleuter, Y.; Dekegel, D.; Galoux, M.; Ghysdael, J.; Burny, A.; Chantrenne, H. Bovine leukemia virus: An exogenous RNA oncogenic virus. Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 1014-1018.
16. Kettmann, R.; Burny, A. Bovine Leukemia Virus. In The Retroviridae; Levy, J.A., Ed.; Plenum Press: New York, NY, USA, 1994; Volume 3, pp. 39-81.
17. Kenyon, S.J.; Piper, C.E. Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus. Infect. Immun. 1977, 16, 891-897.
18. Ferrer, J.F.; Marshak, R.R.; Abt, D.A.; Kenyon, S.J. Relationship between lymphosarcoma and persistent lymphocytosis in cattle: A review. J. Am. Vet. Med. Assoc. 1979, 175, 705-708.
19. Schwartz, I.; Levy, D. Pathobiology of bovine leukemia virus. Vet. Res. 1994, 25, 521-536.
20. Kettmann, R.; Burny, A.; Cleuter, Y.; Ghysdael, J.; Mammerickx, M. Distribution of bovine leukemia virus proviral sequences in tissues of bovine, ovine and human origin. Ann. Rech. Vet. 1978, 9, 837-844.
21. Kettmann, R.; Meunier-Rotival, M.; Cortadas, J.; Cuny, G.; Ghysdael, J.; Mammerickx, M.; Burny, A.; Bernardi, G. Integration of bovine leukemia virus DNA in the bovine genome. Proc. Natl. Acad. Sci. U. S. A. 1979, 76, 4822-4826.
22. Kettmann, R.; Meunier-Rotival, M.; Cortadas, J.; Cuny, G.; Ghysdael, J.; Mammerickx, M.; Burny, A.; Bernardi, G. Integration site of bovine leukemia virus DNA in the bovine genome [proceedings]. Arch. Int. Physiol. Biochim. 1979, 87, 818-819.
23. Kettmann, R.; Cleuter, Y.; Mammerickx, M.; Meunier-Rotival, M.; Bernardi, G.; Burny, A.; Chantrenne, H. Genomic integration of bovine leukemia provirus: Comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 2577-2581.
24. Jacobs, R.M.; Song, Z.; Poon, H.; Heeney, J.L.; Taylor, J.A.; Jefferson, B.; Vernau, W.; Valli, V.E. Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma. Can. J. Vet. Res. 1992, 56, 339-348.
25. Thurmond, M.C. Economics of enzootic bovine leukosis. In Enzootic bovine leukosis and bovine leukemia virus; Burny, A., Mammerickx, M., Eds.; Martinus Nijhoff Publishing: Boston, MA, USA, 1987; pp. 71-86.
26. Pelzer, K.D. Economics of bovine leukemia virus infection. Vet. Clin. North Am. Food Anim. Pract. 1997, 13, 129-141.
27. Trainin, Z.; Brenner, J. The direct and indirect economic impacts of bovine leukemia virus infection on dairy cattle. Isr. J. Vet. Med. 2005, 60, 90-105.
28. Johnson, R.; Gibson, C.D.; Kaneene, J.B. Bovine leukemia virus: A herd-based control strategy. Prev. Vet. Med. 1985, 3, 339-349.
29. Hopkins, S.G.; DiGiacomo, R.F. Natural transmission of bovine leukemia virus in dairy and beef cattle. Vet. Clin. North. Am. Food Anim. Pract. 1997, 13, 107-128.
30. Ohshima, K.; Okada, K.; Numakunai, S.; Yoneyama, Y.; Sato, S.; Takahashi, K. Evidence on horizontal transmission of bovine leukemia virus due to blood-sucking tabanid flies. Nippon Juigaku Zasshi. 1981, 43, 79-81.
31. Perino, L.J.; Wright, R.E.; Hoppe, K.L.; Fulton, R.W. Bovine leukosis virus transmission with mouthparts from Tabanus abactor after interrupted feeding. Am. J. Vet. Res. 1990, 51, 1167-1169.
32. Ferrer, J.F.; Piper, C.E.; Abt, D.A.; Marshak, R.R.; Bhatt, D.M. Natural mode of transmission of the bovine C type leukemia virus (BLV). Bibl. Haematol. 1975, 43, 235-237.
33. Lassauzet, M.L.; Thurmond, M.C.; Johnson, W.O.; Holmberg, C.A. Factors associated with in utero or periparturient transmission of bovine leukemia virus in calves on a California dairy. Can. J. Vet. Res. 1991, 55, 264-268.
34. Piper, C.E.; Ferrer, J.F.; Abt, D.A.; Marshak, R.R. Postnatal and prenatal transmission of the bovine leukemia virus under natural conditions. J. Natl. Cancer Inst. 1979, 62, 165-168.
35. Agresti, A.; Ponti, W.; Rocchi, M.; Meneveri, R.; Marozzi, A.; Cavalleri, D.; Peri, E.; Poli, G.; Ginelli, E. Use of polymerase chain reaction to diagnose bovine leukemia virus infection in calves at birth. Am. J. Vet. Res. 1993, 54, 373-378.
36. Ferrer, J.F.; Piper, C.E. Role of colostrum and milk in the natural transmission of the bovine leukemia virus. Cancer Res. 1981, 41, 4906-4909.
37. Ferrer, J.F.; Piper, C.E. An evaluation of the role of milk in the natural transmission of BLV. Ann. Rech. Vet. 1978, 9, 803-807.
38. Ferrer, J.F.; Kenyon, S.J.; Gupta, P. Milk of dairy cows frequently contains a leukemogenic virus. Science 1981, 213, 1014-1016.
39. Van Der Maaten, M.J.; Miller, J.M.; Schmerr, M.J. Effect of colostral antibody on bovine leukemia virus infection of neonatal calves. Am. J. Vet. Res. 1981, 42, 1498-1500.
40. Van der Maaten, M.J.; Miller, J.M. Susceptibility of cattle to bovine leukemia virus infection by various routes of exposure. In Advances in Comparative Leukemia Research; Bentvelzen, P., Hilgers, J., Yohn, D.S., Eds.; Elsevier/North Holland Biomedical Press: Amsterdam, the Netherlands, 1978; pp. 29-32.
41. Lassauzet, M.L.; Johnson, W.O.; Thurmond, M.C.; Stevens, F. Protection of colostral antibodies against bovine leukemia virus infection in calves on a California dairy. Can. J. Vet. Res. 1989, 53, 424-430.
42. Forschner, E.; Bunger, I.; Krause, H.P. Surveillance investigations of brucellosis-, leukosis- and BHV-free cattle herds. ELISA-based bulk milk studies compared to single animal sample studies with traditional test systems. Safety and cost. Dtsch. Tierarztl. Wochenschr. 1988, 95, 214-218.
43. Knapen, K.; Kerkhofs, P.; Mammerickx, M. Eradication of enzootic bovine leukosis in Belgium: Results of the mass detection on the national cattle population in 1989, 1990 and 1991. Ann. Med. Vet. 1993, 137, 197-201.
44. Nuotio, L.; Rusanen, H.; Sihvonen, L.; Neuvonen, E. Eradication of enzootic bovine leucosis from Finland. Prev. Vet. Med. 2003, 59, 43-49.
45. Acaite, J.; Tamosiunas, V.; Lukauskas, K.; Milius, J.; Pieskus, J. The eradication experience of enzootic bovine leukosis from Lithuania. Prev. Vet. Med. 2007, 82, 83-89.
46. OIE World Animal Health InformationDatabase (WAHID Interface), Version 1.4. Available online: http://web.oie.int/wahis/public.php?page=disease_status_detail (accessed on 27 April 2011).
47. NAHIS-AHA Enzootic Bovine Leukosis. Available online: http://www.animalhealthaustralia.com.au/nahis/pmwiki/pmwiki.php?n=Factsheet.90-1 (accessed on 27 April 2011).
48. Hayes, D.; Burton, L. Enzootic bovine leucosis eradication scheme. Surveillance 1998, 25, 3-5.
49. NAHMS-USDA Bovine Leukosis Virus on U.S. Dairy Operations, 2007. Available online: http://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_is_BLV.pdf (accessed on 27 April 2011).
50. Jacobs, R.M.; Pollari, F.L.; McNab, W.B.; Jefferson, B. A serological survey of bovine syncytial virus in Ontario: associations with bovine leukemia and immunodeficiency-like viruses, production records, and management practices. Can. J. Vet. Res. 1995, 59, 271-278.
51. Van Leeuwen, J.A.; Keefe, G.P.; Tremblay, R.; Power, C.; Wichtel, J.J. Seroprevalence of infection with Mycobacterium avium subspecies paratuberculosis, bovine leukemia virus, and bovine viral diarrhea virus in maritime Canada dairy cattle. Can. Vet. J. 2001, 42, 193-198.
52. Van Leeuwen, J.A.; Forsythe, L.; Tiwari, A.; Chartier, R. Seroprevalence of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in dairy cattle in Saskatchewan. Can. Vet. J. 2005, 46, 56-58.
53. Van Leeuwen, J.A.; Tiwari, A.; Plaizier, J.C.; Whiting, T.L. Seroprevalence of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies partuberculosis, and Neospora caninum in beef and dairy cattle in Manitoba. Can. Vet. J. 2006, 47, 783-786.
54. Scott, H.M.; Sorensen, O.; Wu, J.T.; Chow, E.Y.; Manninen, K.; Van Leeuwen, J.A., Seroprevalence of Mycobacterium avium subspecies paratuberculosis, Neospora caninum, Bovine leukemia virus, and Bovine viral diarrhea virus infection among dairy cattle and herds in Alberta and agroecological risk factors associated with seropositivity. Can. Vet. J. 2006, 47, 981-991.
55. Marin, C.; de López, N.M.; Álvarez, L.; Lozano, O.; España, W.; Castaños, H.; León, A. Epidemiology of bovine leukemia in Venezuela. Ann. Rech. Vet. 1978, 9, 743-746.
56. Islas, L.A.; Inchaurtieta, S.C.; Muñoz, P.G. Prevalencia de leucosis enzoótica bovina (LEB) en lecherías de las comunas de San Fernando, Chimbarongo y Placilla. Monograf. Med. Vet. 1990, 12, 64-70.
57. Alfonso, R.; Almansa, J.E.; Barrera, J.C. Serological prevalence and evaluation of the risk factors of bovine enzootic leukosis in the Bogota savannah and the Ubate and Chiquinquira Valleys, Colombia. Rev. Sci. Tech. 1998, 17, 723-732.
58. Rama, G.; Moratorio, G.; Greif, G.; Obal, G.; Bianchi, S.; Tomé, L.; Carrion, F.; Meikle, A.; Pritsch, O. Development of a real time PCR assay using SYBR Green chemistry for bovine leukemia virus detection. Retrovirology 2011, 8, A17.
59. Trono, K.G.; Perez-Filgueira, D.M.; Duffy, S.; Borca, M.V.; Carrillo, C. Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: Comparison of sensitivity and specificity of different detection methods. Vet. Microbiol. 2001, 83, 235-248.
60. D'Angelino, J.L.; Garcia, M.; Birgel, E.H. Epidemiological study of enzootic bovine leukosis in Brazil. Trop. Anim. Health Prod. 1998, 30, 13-15.
61. Abreu, V.L.V.; Silva, J.A.; Modena, C.M.; Moreira, É.C.; Figueiredo, M.M.N. Prevalência da leucose enzoótica bovina nos estados de Rondônia e Acre. Arq. Bras. Med. Vet. Zootec. 1990, 42, 203-210.
62. Melo, L.E.H. Leucose enzoótica dos bovinos. Prevalência da infecção em rebanhos leiteiros criados no agreste meridional do estado de Pernambuco. Dissertação (Mestrado), Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, Sao Paulo, Brazil, 1991; p. 102.
63. Melo, C.B.; Oliveira, A.M.; Figueiredo, H.C.P.; Leite, R.C.; Lobato, Z.I.P. Prevalência de anticorpos contra Herpesvírus Bovino-1, vírus da Diarréia Bovina a Vírus e vírus da Leucose Enzoótica Bovina em bovinos do Estado de Sergipe, Brasil. Rev. Bras. Reprod. Anim. 1997, 21, 160-161.
64. Molnár, E.; Molnár, L.; Tavares Dias, H.; da Silva, A.O.A.; Gomes Vale, W. Ocorrência da Leucose Enzoótica dos Bovinos no Estado do Pará, Brasil. Pesq. Vet. Bras. 1999, 19, 7-11.
65. Leuzzi Junior, L.Á.; Fernandes Alfieri, A.; Alfieri, A.A. Leucose enzoótica bovina e vírus da leucemia bovina. Semina 2001, 22, 211-221.
66. Cerqueira-Leite, R.; Portela Lobato, Z.I.; Fernandes Camargos, M. Leucose Enzoótica Bovina. Revista CFMFVZ 2001, 24, 20-28.
67. Del Fava, C.; Pituco, E.M. Infecção pelo vírus da leucemia bovina (BLV) no Brasil. Biológico 2004, 66, 1-8.
68. Wang, C.T. Bovine leukemia virus infection in Taiwan: Epizdemiological study. J. Vet. Med. Sci. 1991, 53, 395-398.
69. Meas, S.; Ohashi, K.; Tum, S.; Chhin, M.; Te, K.; Miura, K.; Sugimoto, C.; Onuma, M. Seroprevalence of bovine immunodeficiency virus and bovine leukemia virus in draught animals in Cambodia. J. Vet. Med. Sci. 2000, 62, 779-781.
70. Murakami, K.; Kobayashi, S.; Konishi, M.; Kameyama, K.; Yamamoto, T.; Tsutsui, T. The recent prevalence of bovine leukemia virus (BLV) infection among Japanese cattle. Vet. Microbiol. 2011, 148, 84-88.
71. Suh, G.H.; Lee, J.C.; Lee, C.Y.; Hur, T.Y.; Son, D.S.; Ahn, B.S.; Kim, N.C.; Lee, C.G. Establishment of a bovine leukemia virus-free dairy herd in Korea. J. Vet. Sci. 2005, 6, 227-230.
72. Hafez, S.M.; Sharif, M.; Al-Sukayran, A.; Dela-Cruz, D. Preliminary studies on enzootic bovine leukosis in Saudi dairy farms. Dtsch. Tierarztl. Wochenschr. 1990, 97, 61-63.
73. Meas, S.; Seto, J.; Sugimoto, C.; Bakhsh, M.; Riaz, M.; Sato, T.; Naeem, K.; Ohashi, K.; Onuma, M. Infection of Bovine Immunodeficiency Virus and Bovine Leukemia Virus in Water Buffalo and Cattle Populations in Pakistan. J. Vet. Med. Sci. 2000, 62, 329-331.
74. Pourjafar, M.; Mahzonieh, M.R.; Heidari Borujeni, M. Serological study of bovine viral leucosis in Borujen, Lordegan and Farsan. In Proceedings of the 23rd World Buiatrics Congress, Quebec City, Canada, 11-16 July 2004; p. 338.
75. Burgu, I.; Alkan, F.; Karaoglu, T.; Bilge-Dagalp, S.; Can-Sahna, K.; Gungor, B.; Demir, B. Control and eradication programme of enzootic bovine leucosis (EBL) from selected dairy herds in Turkey. Dtsch. Tierarztl. Wochenschr. 2005, 112, 271-274.
76. Haghparast, A.; Mohammadi, G.; Mousavi, S. Seroepidemiology of bovine leukemia virus (BLV) infection in the north eastern provinces of Iran. In Proceedings of the XVI Congress of the Mediterranean Federation for Health and Production of Ruminants, Zadar, Croatia, 22-26 April 2008; Harapin, I., Kos, J., Eds.; Faculty of Veterinary medicine, Zagreb Croatian Veterinary Chamber: Zadar, Croatia, 2008; p. 504.
77. Brujeni, G.N.; Poorbazargani, T.T.; Nadin-Davis, S.; Tolooie, M.; Barjesteh, N. Bovine immunodeficiency virus and bovine leukemia virus and their mixed infection in Iranian Holstein cattle. J. Infect. Dev. Ctries. 2010, 4, 576-579.
78. Tan, M.T.; Yildirim, Y.; Erol, N.; Gungor, A.B. The seroprevalence of bovine herpes virus type 1 (BHV-1) and bovine leukemia virus (BLV) in selected dairy cattle herds in Aydin province, Turkey. Turk. J. Vet. Anim. Sci. 2006, 30, 353-357.
79. Ferrer, J.F. Bovine leukosis: Natural transmission and principles of control. J. Am. Vet. Med. Assoc. 1979, 175, 1281-1286.
80. DiGiacomo, R.F. The epidemiology and control of bovine leukemia virus infection. Vet. Med. 1992, 87, 248-257.
81. Mammerickx, M.; Cormann, A.; Burny, A.; Dekegel, D.; Portetelle, D. Eradication of enzootic bovine leukosis based on the detection of the disease by the GP immunodiffusion test. Ann. Rech. Vet. 1978, 9, 885-894.
82. Straub, O.C. First results of a new sanitation program concerning the eradication of enzootic bovine leukosis. Ann. Rech. Vet. 1978, 9, 895-898.
83. Maas-Inderwiesen, F.; Albrecht, A.; Bause, I.; Osmers, M.; Schmidt, F.W. Effect of leucosis control on the development of enzootic bovine leukosis in Lower Saxony. Dtsch. Tierarztl. Wochenschr. 1978, 85, 309-313.
84. Van Der Maaten, M.J.; Miller, J.M. Appraisal of control measures for bovine leukosis. J. Am. Vet. Med. Assoc. 1979, 175, 1287-1290.
85. Roberts, D.H.; Bushnell, S. Herd eradication of enzootic bovine leukosis. Vet. Rec. 1982, 111, 487.
86. Schmidt, F.W. In Results and observations of an EBL eradication programme based on AGIDT diagnosis and culling of reactors, Proceedings of the Fourth International Symposium on Bovine Leukosis, Bologna, Italy, 5-7 November 1980; Straub, O.C., Ed.; Martinus Nijhoff Publishing: Dordrecht, The Netherlands, 1982; pp. 491-497.
87. Yoshikawa, T.; Yoshikawa, H.; Koyama, H.; Tsubaki, S. Preliminary attempts to eradicate infection with bovine leukemia virus from a stock farm in Japan. Nippon Juigaku Zasshi 1982, 44, 831-843.
88. Ohshima, K.; Okada, K.; Numakunai, S.; Kayano, H.; Goto, T. An eradication program without economic loss in a herd infected with bovine leukemia virus (BLV). Nippon Juigaku Zasshi 1988, 50, 1074-1078.
89. Wang, C.T.; Onuma, M. Attempt to eradicate bovine leukemia virus-infected cattle from herds. Jpn. J. Vet. Res. 1992, 40, 105-111.
90. Asfaw, Y.; Tsuduku, S.; Konishi, M.; Murakami, K.; Tsuboi, T.; Wu, D.; Sentsui, H. Distribution and superinfection of bovine leukemia virus genotypes in Japan. Arch. Virol. 2005, 150, 493-505.
91. Monti, G.; Schrijver, R.; Beier, D. Genetic diversity and spread of Bovine leukaemia virus isolates in Argentine dairy cattle. Arch. Virol. 2005, 150, 443-458.
92. Shettigara, P.T.; Samagh, B.S.; Lobinowich, E.M. Control of bovine leukemia virus infection in dairy herds by agar gel immunodiffusion test and segregation of reactors. Can. J. Vet. Res. 1989, 53, 108-110.
93. Brenner, J.; Meiron, R.; Avraham, R.; Savir, S.; Trainin, Z. Trial of two methods for the eradication of bovine leucosis virus infection from two large dairy herds in Israel. Isr. J. Vet. Med. 1988, 44, 168-175.
94. Kaja, R.W.; Olson, C.; Rowe, R.F.; Stauffacher, R.H.; Strozinski, L.L.; Hardie, A.R.; Bause, I. Establishment of a bovine leukosis virus-free dairy herd. J. Am. Vet. Med. Assoc. 1984, 184, 184-185.
95. Otachel-Hawranek, J. Eradication of enzootic bovine leukosis in dairy cattle from the lower Silesia region. Bull. Vet. Inst. Pulawy 2007, 51, 465-469.
96. OIE. Enzootic bovine leukosis. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; World Organisation for Animal Health: Paris, France, 2008; Volume 2, Chapter 2.4.11, pp. 729-738.
97. Evermann, J.F.; DiGiacomo, R.F.; Ferrer, J.F.; Parish, S.M. Transmission of bovine leukosis virus by blood inoculation. Am. J. Vet. Res. 1986, 47, 1885-1887.
98. Burridge, M.J.; Thurmond, M.C.; Miller, J.M.; Schmerr, M.J.; Van Der Maaten, M.J. Duration of colostral antibodies to bovine leukemia virus by two serologic tests. Am. J. Vet. Res. 1982, 43, 1866-1867.
99. Burridge, M.J.; Thurmond, M.C.; Miller, J.M.; Schmerr, M.J.; Van Der Maaten, M.J. Fall in antibody titer to bovine leukemia virus in the periparturient period. Can. J. Comp. Med. 1982, 46, 270-271.
100. Lew, A.E.; Bock, R.E.; Miles, J.; Cuttell, L.B.; Steer, P.; Nadin-Davis, S.A. Sensitive and specific detection of bovine immunodeficiency virus and bovine syncytial virus by 5' Taq nuclease assays with fluorescent 3' minor groove binder-DNA probes. J. Virol. Methods 2004, 116, 1-9.
101. Jimba, M.; Takeshima, S.N.; Matoba, K.; Endoh, D.; Aida, Y. BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm. Retrovirology 2010, 7, 91.
102. Juliarena, M.A.; Gutierrez, S.E.; Ceriani, C. Determination of proviral load in bovine leukemia virus-infected cattle with and without lymphocytosis. Am. J. Vet. Res. 2007, 68, 1220-1225.
103. Esteban, E.N.; Poli, M.; Poiesz, B.; Ceriani, C.; Dube, S.; Gutierrez, S.; Dolcini, G.; Gagliardi, R.; Perez, S.; Lützelschwab, C., et al. Bovine leukemia virus (BLV), proposed control and eradication programs by marker assisted breeding of genetically resistant cattle. In Animal Genetics; Rechi, L.J., Eds.; Nova Science Publishers, Inc: Hauppauge, NY, USA, 2009; Chapter 6, pp. 107-130.
104. Gutiérrez, G.; Alvarez, I.; Politzki, R.; Lomónaco, M.; Dus Santos, M.J.; Rondelli, F.; Fondevila, N.; Trono, K. Natural progression of bovine leukemia virus infection in Argentinean dairy cattle. Vet. Microbiol. 2011, in press.
105. Ruppanner, R.; Behymer, D.E.; Paul, S.; Miller, J.M.; Theilen, G.H. A strategy for control of bovine leukemia virus infection: test and corrective management. Can. Vet. J. 1983, 24, 192-195.
106. Sprecher, D.J.; Pelzer, K.D.; Lessard, P. Possible effect of altered management practices on seroprevalence of bovine leukemia virus in heifers of a dairy herd with history of high prevalence of infection. J. Am. Vet. Med. Assoc. 1991, 199, 584-588.
107. Bacon, L.D. Influence of the major histocompatibility complex on disease resistance and productivity. Poult. Sci. 1987, 66, 802-11.
108. Gogolin-Ewens, K.J.; Meeusen, E.N.; Scott, P.C.; Adams, T.E.; Brandon, M.R. Genetic selection for disease resistance and traits of economic importance in animal production. Rev. Sci. Tech. 1990, 9, 865-896.
109. Warner, C.M.; Meeker, D.L.; Rothschild, M.F. Genetic control of immune responsiveness: A review of its use as a tool for selection for disease resistance. J. Anim. Sci. 1987, 64, 394-406.
110. Lamont, S.J. Impact of genetics on disease resistance. Poult. Sci. 1998, 77, 1111-1118.
111. Amorena, B.; Stone, W.H. Serologically defined (SD) locus in cattle. Science 1978, 201, 159-160.
112. Spooner, R.L.; Leveziel, H.; Grosclaude, F.; Oliver, R.A.; Vaiman, M. Evidence for a possible major histocompatibility complex (BLA) in cattle. J. Immunogenet. 1978, 5, 325-346.
113. Spooner, R.L.; Oliver, R.A.; Sales, D.I.; McCoubrey, C.M.; Millar, P.; Morgan, A.G.; Amorena, B.; Bailey, E.; Bernoco, D.; Brandon, M., et al. Analysis of alloantisera against bovine lymphocytes. Joint report of the 1st International Bovine Lymphocyte Antigen (BoLA) workshop. Anim. Blood Groups Biochem. Genet. 1979, 10, 63-86.
114. Burridge, M.J.; Wilcox, C.J.; Hennemann, J.M. Influence of genetic factors on the susceptibility of cattle to bovine leukemia virus infection. Eur. J. Cancer 1979, 15, 1395-1400.
115. Lewin, H.A.; Bernoco, D. Evidence for BoLA-linked resistance and susceptibility to subclinical progression of bovine leukaemia virus infection. Anim. Genet. 1986, 17, 197-207.
116. Stear, M.J.; Dimmock, C.K.; Newman, M.J.; Nicholas, F.W. BoLA antigens are associated with increased frequency of persistent lymphocytosis in bovine leukaemia virus infected cattle and with increased incidence of antibodies to bovine leukaemia virus. Anim. Genet. 1988, 19, 151-158.
117. Lewin, H.A.; Wu, M.C.; Stewart, J.A.; Nolan, T.J. Association between BoLA and subclinical bovine leukemia virus infection in a herd of Holstein-Friesian cows. Immunogenetics 1988, 27, 338-344.
118. Bull, R.W.; Lewin, H.A.; Wu, M.C.; Peterbaugh, K.; Antczak, D.; Bernoco, D.; Cwik, S.; Dam, L.; Davies, C.; Dawkins, R.L., et al. Joint report of the Third International Bovine Lymphocyte Antigen (BoLA) Workshop, Helsinki, Finland, 27 July 1986. Anim. Genet. 1989, 20, 109-132.
119. Palmer, C.; Thurmond, M.; Picanso, J.; Brewer, A.W.; Bernoco, D. In Susceptibility of cattle bovine leukemia virus infection associated with BoLA type, Proceedings of the 91st Annual Meeting of United States Animal Health Association, Salk Lake City, UT, USA, 25-30 October 1987; United States Animal Health Association: Richmond, VA, USA, 1987; pp. 218-228.
120. van Eijk, M.J.; Stewart-Haynes, J.A.; Beever, J.E.; Fernando, R.L.; Lewin, H.A. Development of persistent lymphocytosis in cattle is closely associated with DRB2. Immunogenetics 1992, 37, 64-68.
121. Xu, A.; van Eijk, M.J.; Park, C.; Lewin, H.A. Polymorphism in BoLA-DRB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus. J. Immunol. 1993, 151, 6977-6985.
122. van Eijk, M.J.; Stewart-Haynes, J.A.; Lewin, H.A. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 1992, 23, 483-496.
123. Burke, M.G.; Stone, R.T.; Muggli-Cockett, N.E. Nucleotide sequence and northern analysis of a bovine major histocompatibility class II DR beta-like cDNA. Anim. Genet. 1991, 22, 343-352.
124. Mirsky, M.L.; Olmstead, C.; Da, Y.; Lewin, H.A. Reduced bovine leukaemia virus proviral load in genetically resistant cattle. Anim. Genet. 1998, 29, 245-252.
125. Zanotti, M.; Poli, G.; Ponti, W.; Polli, M.; Rocchi, M.; Bolzani, E.; Longeri, M.; Russo, S.; Lewin, H.A.; van Eijk, M.J. Association of BoLA class II haplotypes with subclinical progression of bovine leukaemia virus infection in Holstein-Friesian cattle. Anim. Genet. 1996, 27, 337-341.
126. Udina, I.G.; Karamysheva, E.E.; Turkova, S.O.; Orlova, A.R.; Sulimova, G.E. Genetic mechanisms of resistance and susceptibility to leukemia in Ayrshire and black pied cattle breeds determined by allelic distribution of gene Bola-DRB3. Genetika 2003, 39, 383-396.
127. Juliarena, M.A.; Poli, M.; Sala, L.; Ceriani, C.; Gutierrez, S.; Dolcini, G.; Rodriguez, E.M.; Marino, B.; Rodriguez-Dubra, C.; Esteban, E.N. Association of BLV infection profiles with alleles of the BoLA-DRB3.2 gene. Anim. Genet. 2008, 39, 432-438.
128. Takashima, I.; Olson, C. Histocompatibility antigens in bovine lymphosarcoma. A preliminary study. Ann. Rech. Vet. 1978, 9, 821-823.
129. Aida, Y. Influence of host genetic diffences on leukemogenesis induced bovine leukaemia virus. AIDS Res. Hum. Retroviruses 2001, 17, 12.
130. Nagaoka, Y.; Kabeya, H.; Onuma, M.; Kasai, N.; Okada, K.; Aida, Y. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma. Cancer Res. 1999, 59, 975-981.
131. Kabeya, H.; Ohashi, K.; Oyunbileg, N.; Nagaoka, Y.; Aida, Y.; Sugimoto, C.; Yokomizo, Y.; Onuma, M. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovineleukemia virus (BLV) elimination in the early phase of infection. Vet. Immunol. Immunopathol. 1999, 68, 255-265.
132. Konnai, S.; Usui, T.; Ikeda, M.; Kohara, J.; Hirata, T.; Okada, K.; Ohashi, K.; Onuma, M. Tumor necrosis factor-alpha genetic polymorphism may contribute to progression of bovine leukemia virus-infection. Microbes Infect. 2006, 8, 2163-2171.
133. Bojarojc-Nosowicz, B.; Kaczmarczyk, E. Somatic cell count and chemical composition of milk in naturally BLV-infected cows with different phenotypes of blood leukocyte acid phosphatase. Archiv. für Tierzucht. 2006, 49, 17-28.
134. Lewin, H.A. Disease resistance and immune response genes in cattle: Strategies for their detection and evidence of their existence. J. Dairy Sci. 1989, 72, 1334-1348.
135. Lander, E.S.; Schork, N.J. Genetic dissection of complex traits. Science 1994, 265, 2037-2048.
136. Kramnik, I.; Boyartchuk, V. Immunity to intracellular pathogens as a complex genetic trait. Curr. Opin. Microbiol. 2002, 5, 111-117.
137. Glass, E.J.; Baxter, R.; Leach, R.; Taylor, G. Bovine viral diseases: The role of host genetics. In Breeding for Disease Resistance in Farm Animals, 3rd ed.; Bishop, S.C., Axford, R.F.E., Owen, J., Nicholas, F., Eds.; CAB International: Oxfordshire, UK, 2011; Chapter 6, pp. 88-140.
138. Williams, J.L. The use of marker-assisted selection in animal breeding and biotechnology. Rev. Sci. Tech. Off. Int. Epiz. 2005, 24, 379-391.
139. Juliarena, M.A.; Poli, M.; Ceriani, C.; Sala, L.; Rodriguez, E.; Gutierrez, S.; Dolcini, G.; Odeon, A.; Esteban, E.N. Antibody response against three widespread bovine viruses is not impaired in Holstein cattle carrying bovine leukocyte antigen DRB3.2 alleles associated with bovine leukemia virus resistance. J. Dairy Sci. 2009, 92, 375-381.
140. Ng, H.H.; Bird, A. Histone deacetylases: Silencers for hire. Trends Biochem. Sci. 2000, 25, 121-126.
141. Graessle, S.; Loidl, P.; Brosch, G. Histone acetylation: Plants and fungi as model systems for the investigation of histone deacetylases. Cell. Mol. Life Sci. 2001, 58, 704-720.
142. Czermin, B.; Imhof, A. The sounds of silence-histone deacetylation meets histone methylation. Genetica 2003, 117, 159-164.
143. Yoo, C.B.; Jones, P.A. Epigenetic therapy of cancer: Past, present and future. Nat. Rev. Drug Discov. 2006, 5, 37-50.
144. Papait, R.; Monti, E.; Bonapace, I.M. Novel approaches on epigenetics. Curr. Opin. Drug Discov. Devel. 2009, 12, 264-275.
145. Wanczyk, M.; Roszczenko, K.; Marcinkiewicz, K.; Bojarczuk, K.; Kowara, M.; Winiarska, M. HDACi-going through the mechanisms. Front. Biosci. 2011, 16, 340-359.
146. de Ruijter, A.J.; van Gennip, A.H.; Caron, H.N.; Kemp, S.; van Kuilenburg, A.B. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 2003, 370, 737-749.
147. Kettmann, R.; Marbaix, G.; Cleuter, Y.; Portetelle, D.; Mammerickx, M.; Burny, A. Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk. Res. 1980, 4, 509-519.
148. Gupta, P.; Ferrer, J.F. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science 1982, 215, 405-407.
149. Kashmiri, S.V.; Mehdi, R.; Gupta, P.; Ferrer, J.F. Methylation and expression of bovine leukemia proviral DNA. Biochem. Biophys. Res. Commun. 1985, 129, 126-133.
150. Van den Broeke, A.; Cleuter, Y.; Chen, G.; Portetelle, D.; Mammerickx, M.; Zagury, D.; Fouchard, M.; Coulombel, L.; Kettmann, R.; Burny, A. Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 9263-3267.
151. Lagarias, D.M.; Radke, K. Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J. Virol. 1989, 63, 2099-2107.
152. Merimi, M.; Klener, P.; Szynal, M.; Cleuter, Y.; Bagnis, C.; Kerkhofs, P.; Burny, A.; Martiat, P.; Van den Broeke, A. Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: Observations in Bovine Leukemia Virus-infected sheep. Retrovirology 2007, 4, 51.
153. Merimi, M.; Klener, P.; Szynal, M.; Cleuter, Y.; Kerkhofs, P.; Burny, A.; Martiat, P.; Van den Broeke, A. Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code. J. Virol. 2007, 81, 5929-5939.
154. Kerkhofs, P.; Adam, E.; Droogmans, L.; Portetelle, D.; Mammerickx, M.; Burny, A.; Kettmann, R.; Willems, L. Cellular pathways involved in the ex vivo expression of bovine leukemia virus. J. Virol. 1996, 70, 2170-2177.
155. Merezak, C.; Reichert, M.; Van Lint, C.; Kerkhofs, P.; Portetelle, D.; Willems, L.; Kettmann, R. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J. Virol. 2002, 76, 5034-5042.
156. Tajima, S.; Tsukamoto, M.; Aida, Y. Latency of viral expression in vivo is not related to CpG methylation in the U3 region and part of the R region of the long terminal repeat of bovine leukemia virus. J. Virol. 2003, 77, 4423-4430.
157. Calomme, C.; Dekoninck, A.; Nizet, S.; Adam, E.; Nguyen, T.L.; Van Den Broeke, A.; Willems, L.; Kettmann, R.; Burny, A.; Van Lint, C. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. J. Virol. 2004, 78, 13848-13864.
158. Nguyen, T.L.; Calomme, C.; Wijmeersch, G.; Nizet, S.; Veithen, E.; Portetelle, D.; de Launoit, Y.; Burny, A.; Van Lint, C. Deacetylase inhibitors and the viral transactivator TaxBLV synergistically activate bovine leukemia virus gene expression via a cAMP-responsive elementand cAMP-responsive element-binding protein-dependent mechanism. J. Biol. Chem. 2004, 279, 35025-35036.
159. Achachi, A.; Florins, A.; Gillet, N.; Debacq, C.; Urbain, P.; Foutsop, G.M.; Vandermeers, F.; Jasik, A.; Reichert, M.; Kerkhofs, P., et al. Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 10309-10314.
160. Pierard, V.; Guiguen, A.; Colin, L.; Wijmeersch, G.; Vanhulle, C.; Van Driessche, B.; Dekoninck, A.; Blazkova, J.; Cardona, C.; Merimi, M., et al. DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding. J. Biol. Chem. 2010, 285, 19434-19449.
161. Merezak, C.; Pierreux, C.; Adam, E.; Lemaigre, F.; Rousseau, G.G.; Calomme, C.; Van Lint, C.; Christophe, D.; Kerkhofs, P.; Burny, A., et al. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: Implications for viral latency. J. Virol. 2001, 75, 6977-6988.
162. Gillet, N.; Florins, A.; Boxus, M.; Burteau, C.; Nigro, A.; Vandermeers, F.; Balon, H.; Bouzar, A.B.; Defoiche, J.; Burny, A., et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: Prospects for novel anti-retroviral therapies in human. Retrovirology 2007, 4, 18.
163. Lezin, A.; Gillet, N.; Olindo, S.; Signate, A.; Grandvaux, N.; Verlaeten, O.; Belrose, G.; de Carvalho Bittencourt, M.; Hiscott, J.; Asquith, B., et al. Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood 2007, 110, 3722-3728.
164. Bouzar, A.B.; Boxus, M.; Defoiche, J.; Berchem, G.; Macallan, D.; Pettengell, R.; Willis, F.; Burny, A.; Lagneaux, L.; Bron, D., et al. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br. J. Haematol. 2009, 144, 41-52.
165. Ramos, J.C.; Toomey, N.; Diaz, L.; Ruiz, P.; Barber, G.; Harrington, W., Jr. Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma. Retrovirology 2011, 8, A48.
166. Olindo, S.; Belrose, G.; Gillet, N.; Rodríguez, S.M.; Asquith, B.; Bangham, C.; Signaté, A.; Smadja, D.; Lezin, A.; Césaire, R., et al. Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood 2011, submitted for publication.
167. Afonso, P.V.; Mekaouche, M.; Mortreux, F.; Toulza, F.; Moriceau, A.; Wattel, E.; Gessain, A.; Bangham, C.R.; Dubreuil, G.; Plumelle, Y., et al. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood 2010, 116, 3802-3808.
168. Willems, L.; Portetelle, D.; Kerkhofs, P.; Chen, G.; Burny, A.; Mammerickx, M.; Kettmann, R. In vivo transfection of bovine leukemia provirus into sheep. Virology 1992, 189, 775-7.
169. Willems, L.; Kettmann, R.; Dequiedt, F.; Portetelle, D.; Voneche, V.; Cornil, I.; Kerkhofs, P.; Burny, A.; Mammerickx, M. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 1993, 67, 4078-4085.
170. Willems, L.; Burny, A.; Collete, D.; Dangoisse, O.; Dequiedt, F.; Gatot, J.S.; Kerkhofs, P.; Lefebvre, L.; Merezak, C.; Peremans, T., et al. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retroviruses 2000, 16, 1787-1795.
171. Miller, J.M.; Van Der Maaten, M.J. Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle. Ann. Rech. Vet. 1978, 9, 871-877.
172. Patrascu, I.V.; Coman, S.; Sandu, I.; Stiube, P.; Munteanu, I.; Coman, T.; Ionescu, M.; Popescu, D.; Mihailescu, D. Specific protection against bovine leukemia virus infection conferred on cattle by the Romanian inactivated vaccine BL-VACC-RO. Virologie 1980, 31, 95-102.
173. Parfanovich, M.I.; Zhdanov, V.M.; Lazarenko, A.A.; Nomm, E.M.; Simovart Yu, A.; Parakin, V.K.; Lemesh, V.M. The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV. Br. Vet. J. 1983, 139, 137-146.
174. Miller, J.M.; Van der Maaten, M.J.; Schmerr, M.J. Vaccination of cattle with binary ethyleniminetreated bovine leukemia virus. Am. J. Vet. Res. 1983, 44, 64-67.
175. Fukuyama, S.; Kodama, K.; Hirahara, T.; Nakajima, N.; Takamura, K.; Sasaki, O.; Imanishi, J. Protection against bovine leukemia virus infection by use of inactivated vaccines in cattle. J. Vet. Med. Sci. 1993, 55, 99-106.
176. Ristau, E.; Beier, D.; Wittmann, W. The course of infection with bovine leukosis virus (BLV) in alves after the administration of cell extract from lymph node tumors of BLV-infected cattle. Arch. Exp. Veterinarmed. 1987, 41, 323-331.
177. Ristau, E.; Beier, D.; Wittmann, W.; Klima, F. Protection of sheep against infection with bovine eukemia virus by vaccination with tumor cells or tumor cell preparations from lymph nodes of leukemic cattle. Arch. Exp. Veterinarmed. 1987, 41, 185-196.
178. Onuma, M.; Hodatsu, T.; Yamamoto, S.; Higashihara, M.; Masu, S.; Mikami, T.; Izawa, H. Protection by vaccination against bovine leukemia virus infection in sheep. Am. J. Vet. Res. 1984, 45, 1212-1215.
179. Altaner, C.; Altanerova, V.; Ban, J.; Janik, V.; Volejnicek, V.; Frajs, Z.; Cerny, L. Cell-derived vaccine against bovine leukaemia virus infection. Zentralbl. Veterinarmed. B 1988, 35, 736-746.
180. Altaner, C.; Ban, J.; Altanerova, V.; Janik, V. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine. Vaccine 1991, 9, 889-895.
181. Miller, J.M.; Van der Maaten, M.J.; Schmerr, M.J.F. Vaccination with glycosidase-treated glycoprotein antigen does not prevent bovine leukosis virus infection in cattle. In Proceedings of the Fifth International Symposium on Bovine Leukosis, Tubingen, Germany, 19-21 October 1982; Straub, O.C., Ed.; Office for official publications of the European Communities: Luxembourg, 1984.
182. Burkhardt, H.; Rosenthal, S.; Wittmann, W.; Starick, E.; Scholz, D.; Rosenthal, H.A.; Kluge, K.H. Immunization of young cattle with gp51 of the bovine leukosis virus and the subsequent experimental infection. Arch. Exp. Veterinarmed. 1989, 43, 933-942.
183. Merza, M.; Sober, J.; Sundquist, B.; Toots, I.; Morein, B. Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51. Arch. Virol. 1991, 120, 219-231.
184. Kabeya, H.; Ohashi, K.; Ohishi, K.; Sugimoto, C.; Amanuma, H.; Onuma, M. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. Vaccine 1996, 14, 1118-1122.
185. Mamoun, R.Z.; Morisson, M.; Rebeyrotte, N.; Busetta, B.; Couez, D.; Kettmann, R.; Hospital, M.; Guillemain, B. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J. Virol. 1990, 64, 4180-4188.
186. Willems, L.; Thienpont, E.; Kerkhofs, P.; Burny, A.; Mammerickx, M.; Kettmann, R. Bovine leukemia virus, an animal model for the study of intrastrain variability. J. Virol. 1993, 67, 1086-1089.
187. Fechner, H.; Blankenstein, P.; Looman, A.C.; Elwert, J.; Geue, L.; Albrecht, C.; Kurg, A.; Beier, D.; Marquardt, O.; Ebner, D. Provirus variants of the bovine leukemia virus and their relation to the serological status of naturally infected cattle. Virology 1997, 237, 261-269.
188. Beier, D.; Blankenstein, P.; Marquardt, O.; Kuzmak, J. Identification of different BLV provirus isolates by PCR, RFLPA and DNA sequencing. Berl. Munch. Tierarztl. Wochenschr. 2001, 114, 252-256.
189. Camargos, M.F.; Pereda, A.; Stancek, D.; Rocha, M.A.; dos Reis, J.K.; Greiser-Wilke, I.; Leite, R.C. Molecular characterization of the env gene from Brazilian field isolates of Bovine leukemia virus. Virus Genes 2007, 34, 343-350.
190. Licursi, M.; Inoshima, Y.; Wu, D.; Yokoyama, T.; González, E.T.; Sentsui, H. Provirus variants of bovine leukemia virus in naturally infected cattle from Argentina and Japan. Vet. Microbiol. 2003, 96, 17-23.
191. Felmer, R.; Munoz, G.; Zuniga, J.; Recabal, M. Molecular analysis of a 444 bp fragment of the bovine leukaemia virus gp51 env gene reveals a high frequency of non-silent point mutations and suggests the presence of two subgroups of BLV in Chile. Vet. Microbiol. 2005, 108, 39-47.
192. Hemmatzadeh, F. Sequencing and phylogenetic analysis of gp51 gene of bovine leukaemia virus in Iranian isolates. Vet. Res. Commun. 2007, 31, 783-789.
193. Zhao, X.; Buehring, G.C. Natural genetic variations in bovine leukemia virus envelope gene: possible effects of selection and escape. Virology 2007, 366, 150-165.
194. Rodríguez, S.M.; Golemba, M.D.; Campos, R.H.; Trono, K.; Jones, L.R. Bovine leukemia virus can be classified into seven genotypes: evidence for the existence of two novel clades. J. Gen. Virol. 2009, 90, 2788-2797.
195. Moratorio, G.; Obal, G.; Dubra, A.; Correa, A.; Bianchi, S.; Buschiazzo, A.; Cristina, J.; Pritsch, O. Phylogenetic analysis of bovine leukemia viruses isolated in South America reveals diversification in seven distinct genotypes. Arch. Virol. 2010, 155, 481-489.
196. Matsumura, K.; Inoue, E.; Osawa, Y.; Okazaki, K. Molecular epidemiology of bovine leukemia virus associated with enzootic bovine leukosis in Japan. Virus Res. 2011, 155, 343-348.
197. Bruck, C.; Mathot, S.; Portetelle, D.; Berte, C.; Franssen, J.D.; Herion, P.; Burny, A. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 1982, 122, 342-352.
198. Bruck, C.; Portetelle, D.; Burny, A.; Zavada, J. Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions. Virology 1982, 122, 353-362.
199. Bruck, C.; Portetelle, D.; Mammerickx, M.; Mathot, S.; Burny, A. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep. Leuk. Res. 1984, 8, 315-321.
200. Bruck, C.; Rensonnet, N.; Portetelle, D.; Cleuter, Y.; Mammerickx, M.; Burny, A.; Mamoun, R.; Guillemain, B.; van der Maaten, M.J.; Ghysdael, J. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: Their dependence on protein glycosylation and genetic variability. Virology 1984, 136, 20-31.
201. Portetelle, D.; Bruck, C.; Mammerickx, M.; Burny, A. In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety. Virology 1980, 105, 223-233.
202. Portetelle, D.; Couez, D.; Bruck, C.; Kettmann, R.; Mammerickx, M.; Van der Maaten, M.; Brasseur, R.; Burny, A. Antigenic variants of bovine leukemia virus (BLV) are defined by amino cid substitutions in the NH2 part of the envelope glycoprotein gp51. Virology 1989, 169, 27-33.
203. Portetelle, D.; Dandoy, C.; Burny, A.; Zavada, J.; Siakkou, H.; Gras-Masse, H.; Drobecq, H.; Tartar, A. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51. Virology 1989, 169, 34-41.
204. Thurmond, M.C.; Carter, R.L.; Puhr, D.M.; Burridge, M.J. Decay of colostral antibodies to bovine leukemia virus with application to detection of calfhood infection. Am. J. Vet. Res. 1982, 43, 1152-1155.
205. Jacobsen, K.L.; Bull, R.W.; Miller, J.M.; Herdt, T.H.; Kaneene, J.B. Transmission of bovine leukemia virus: prevalence of antibodies in precolostral calves. Prev. Vet. Med. 1983, 1, 265-272.
206. Lassauzet, M.L.; Johnson, W.O.; Thurmond, M.C.; Stevens, F. Factors associated with decay of colostral antibodies to bovine leukemia virus infection. Prev. Vet. Med. 1990, 9, 45-58.
207. Nagy, D.W.; Tyler, J.W.; Kleiboeker, S.B. Decreased periparturient transmission of bovine leukosis virus in colostrum-fed calves. J. Vet. Intern. Med. 2007, 21, 1104-1107.
208. Kono, Y.; Arai, K.; Sentsui, H.; Matsukawa, S.; Itohara, S. Protection against bovine leukemia virus infection in sheep by active and passive immunization. Nippon Juigaku Zasshi 1986, 48, 117-125.
209. Portetelle, D.; Limbach, K.; Burny, A.; Mammerickx, M.; Desmettre, P.; Riviere, M.; Zavada, J.; Paoletti, E. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine 1991, 9, 194-200.
210. Gatei, M.H.; Naif, H.M.; Kumar, S.; Boyle, D.B.; Daniel, R.C.; Good, M.F.; Lavin, M.F. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: Correlation of protection with CD4 T-cell response to gp51 peptide 51-70. J. Virol. 1993, 67, 1803-1810.
211. Burny, A. Comparative approach to retroviral vaccines. AIDS Res. Hum. Retroviruses 1996, 12, 389-392.
212. Kumar, S.; Andrew, M.E.; Boyle, D.B.; Brandon, R.B.; Lavin, M.F.; Daniel, R.C. Expression of bovine leukaemia virus envelope gene by recombinant vaccinia viruses. Virus Res. 1990, 17, 131-142.
213. Ohishi, K.; Suzuki, H.; Maruyama, T.; Yamamoto, T.; Funahashi, S.; Miki, K.; Ikawa, Y.; Sugimoto, M. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein. Am. J. Vet. Res. 1990, 51, 1170-1173.
214. Ohishi, K.; Suzuki, H.; Yamamoto, T.; Maruyama, T.; Miki, K.; Ikawa, Y.; Numakunai, S.; Okada, K.; Ohshima, K.; Sugimoto, M. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity. J. Gen. Virol. 1991, 72, 1887-1892.
215. Okada, K.; Ikeyama, S.; Ohishi, K.; Suzuki, H.; Sugimoto, M.; Numakunai, S.; Chiba, T.; Murakami, K.; Davis, W.C.; Ohshima, K., et al. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein. Vet. Pathol. 1993, 30, 104-110.
216. Ohishi, K.; Ikawa, Y. T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine. AIDS Res. Hum. Retroviruses 1996, 12, 393-398.
217. Ohishi, K.; Suzuki, H.; Yasutomi, Y.; Onuma, M.; Okada, K.; Numakunai, S.; Ohshima, K.; Ikawa, Y.; Sugimoto, M. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication. Microbiol. Immunol. 1992, 36, 1317-1323.
218. Cherney, T.M.; Schultz, R.D. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes. Am. J. Vet. Res. 1996, 57, 812-818.
219. Von Beust, B.R.; Brown, W.C.; Estes, D.M.; Zarlenga, D.S.; McElwain, T.F.; Palmer, G.H. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12. Vaccine 1999, 17, 384-395.
220. Callebaut, I.; Mornon, J.P.; Burny, A.; Portetelle, D. The bovine leukemia virus (BLV) envelope lycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: Mapping of functional sites through immunological and structural data. Leukemia 1994, 8, 218-221.
221. Ohishi, K.; Kabeya, H.; Amanuma, H.; Onuma, M. Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. Vaccine 1996, 14, 1143-1148.
222. Ohishi, K.; Kabeya, H.; Amanuma, H.; Onuma, M. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity. Leukemia 1997, 11, 223-226.
223. Okada, K.; Sonoda, K.; Koyama, M.; Yin, S.; Ikeda, M.; Goryo, M.; Chen, S.L.; Kabeya, H.; Ohishi, K.; Onuma, M. Delayed-type hypersensitivity in sheep induced by synthetic peptides of bovine leukemia virus encapsulated in mannan-coated liposome. J. Vet. Med. Sci. 2003, 65, 515-518.
224. Hislop, A.D.; Good, M.F.; Mateo, L.; Gardner, J.; Gatei, M.H.; Daniel, R.C.; Meyers, B.V.; Lavin, M.F.; Suhrbier, A. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nat. Med. 1998, 4, 1193-1196.
225. Mateo, L.; Gardner, J.; Suhrbier, A. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine. AIDS Res. Hum. Retroviruses. 2001, 17, 1447-1453.
226. Brillowska, A.; Dabrowski, S.; Rulka, J.; Kubis, P.; Buzala, E.; Kur, J. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination. Acta Biochim. Pol. 1999, 46, 971-976.
227. Usui, T.; Konnai, S.; Tajima, S.; Watarai, S.; Aida, Y.; Ohashi, K.; Onuma, M. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep. J. Vet. Med. Sci. 2003, 65, 1201-1205.
228. Sakakibara, N.; Kabeya, H.; Ohashi, K.; Sugimoto, C.; Onuma, M. Epitope mapping of bovine leukemia virus transactivator protein tax. J. Vet. Med. Sci. 1998, 60, 599-605.
229. Van den Broeke, A.; Oumouna, M.; Beskorwayne, T.; Szynal, M.; Cleuter, Y.; Babiuk, S.; Bagnis, C.; Martiat, P.; Burny, A.; Griebel, P. Cytotoxic responses to BLV tax oncoprotein do not prevent leukemogenesis in sheep. Leuk. Res. 2010, 34, 1663-1669.
230. Boris-Lawrie, K.; Temin, H.M. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex. J. Virol. 1995, 69, 1920-1924.
231. Boris-Lawrie, K.; Altanerova, V.; Altaner, C.; Kucerova, L.; Temin, H.M. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. J. Virol. 1997, 71, 1514-1520.
232. Kucerova, L.; Altanerova, V.; Altaner, C.; Boris-Lawrie, K. Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J. Virol. 1999, 73, 8160-8166.
233. Kerkhofs, P.; Gatot, J.S.; Knapen, K.; Mammerickx, M.; Burny, A.; Portetelle, D.; Willems, L.; Kettmann, R. Long-term protection against bovine leukaemia virus replication in cattle and sheep. J. Gen. Virol. 2000, 81, 957-963.
234. Reichert, M.; Cantor, G.H.; Willems, L.; Kettmann, R. Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes. J. Gen. Virol. 2000, 81, 965-969.
235. Altanerova, V.; Holicova, D.; Kucerova, L.; Altaner, C.; Lairmore, M.D.; Boris-Lawrie, K. Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology 2004, 329, 434-439.
236. Debacq, C.; Sanchez Alcaraz, M.T.; Mortreux, F.; Kerkhofs, P.; Kettmann, R.; Willems, L. Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants. Retrovirology 2004, 1, 31.
237. Florins, A.; Gillet, N.; Boxus, M.; Kerkhofs, P.; Kettmann, R.; Willems, L. Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep. J. Virol. 2007, 81, 10195-10200.
238. Willems, L.; Kerkhofs, P.; Attenelle, L.; Burny, A.; Portetelle, D.; Kettmann, R. The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo. J. Gen. Virol. 1997, 78, 637-640.
239. Willems, L.; Gatot, J.S.; Mammerickx, M.; Portetelle, D.; Burny, A.; Kerkhofs, P.; Kettmann, R. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J. Virol. 1995, 69, 4137-4141.
240. Willems, L.; Kerkhofs, P.; Dequiedt, F.; Portetelle, D.; Mammerickx, M.; Burny, A.; Kettmann, R. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 11532-11536.
241. Bartoe, J.T.; Albrecht, B.; Collins, N.D.; Robek, M.D.; Ratner, L.; Green, P.L.; Lairmore, M.D. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 2000, 74, 1094-1100.
242. Collins, N.D.; Newbound, G.C.; Albrecht, B.; Beard, J.L.; Ratner, L.; Lairmore, M.D. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 1998, 91, 4701-4707.
243. Silverman, L.R.; Phipps, A.J.; Montgomery, A.; Ratner, L.; Lairmore, M.D. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 2004, 78, 3837-3845.
244. Seiki, M.; Hattori, S.; Hirayama, Y.; Yoshida, M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. U. S. A. 1983, 80, 3618-3622.
245. Sagata, N.; Yasunaga, T.; Tsuzuku-Kawamura, J.; Ohishi, K.; Ogawa, Y.; Ikawa, Y. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 677-681.
246. Matsuoka, M.; Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280.
247. Taniguchi, Y.; Nosaka, K.; Yasunaga, J.; Maeda, M.; Mueller, N.; Okayama, A.; Matsuoka, M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005, 2, 64.
248. Wattel, E.; Cavrois, M.; Gessain, A.; Wain-Hobson, S. Clonal expansion of infected cells: a way of life for HTLV-I. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 13, 92-99.
249. Mortreux, F.; Leclercq, I.; Gabet, A.S.; Leroy, A.; Westhof, E.; Gessain, A.; Wain-Hobson, S.; Wattel, E. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J. Natl. Cancer Inst. 2001, 93, 367-377.
250. Sibon, D.; Gabet, A.S.; Zandecki, M.; Pinatel, C.; Thete, J.; Delfau-Larue, M.H.; Rabaaoui, S.; Gessain, A.; Gout, O.; Jacobson, S.; Mortreux, F.; Wattel, E. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J. Clin. Invest. 2006, 116, 974-983.
251. Willems, L.; Gegonne, A.; Chen, G.; Burny, A.; Kettmann, R.; Ghysdael, J. The bovine leukemia virus p34 is a transactivator protein. EMBO J. 1987, 6, 3385-3389.
252. Willems, L.; Heremans, H.; Chen, G.; Portetelle, D.; Billiau, A.; Burny, A.; Kettmann, R. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J. 1990, 9, 1577-1581.
253. Burny, A.; Cleuter, Y.; Couez, D.; Dandoy, C.; Gras-Masse, H.; Gregoire, D.; Kettmann, R.; Mammerickx, M.; Marbaix, G.; Portetelle, D., et al. Bovine leukemia Virus (BLV) as a model system for human lymphotropic virus (HTLV) and HTLV as a model for BLV. In Proceedings of the XIIth Symposium for Comparative Research on Leukemia and Related Diseases, Hamburg, Germany, 7-11 July 1985; pp. 336-348.
254. Willems, L.; Burny, A.; Dangoisse, O.; Dequiedt, F.; Gatot, J.S.; Kerkhofs, P.; Lefebvre, L.; Merezak, C.; Portatelle, D.; Twizere, J.C.; Kettmann, R. Bovine leukemia virus as a model for the human T-cell leukemia. Curr. Top. Virol. 1999, 16, 1787-1795.
255. Willems, L. Bovine leukemia virus as a model for studying human leukemias. Bull. Mem. Acad. R. Med. Belg. 2004, 159, 473-478.
256. Lezin, A.; Olindo, S.; Belrose, G.; Signate, A.; Cesaire, R.; Smadja, D.; Macallan, D.; Asquith, B.; Bangham, C.; Bouzar, A., et al. Gene activation therapy: from the BLV model to HAM/TSP patients. Front. Biosci. 2009, 1, 205-215.
257. Boxus, M.; Willems, L. Mechanisms of HTLV-1 persistence and transformation. Br. J. Cancer 2009, 101, 1497-1501.
258. Diamond, G.A.; Denton, T.A. Alternative perspectives on the biased foundations of medical technology assessment. Ann. Intern. Med. 1993, 118, 455-464.
259. Nakano, S.; Ando, Y.; Saito, K.; Moriyama, I.; Ichijo, M.; Toyama, T.; Sugamura, K.; Imai, J.; Hinuma, Y. Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J. Infect. 1986, 12, 205-212.
260. Hino, S.; Yamaguchi, K.; Katamine, S.; Sugiyama, H.; Amagasaki, T.; Kinoshita, K.; Yoshida, Y.; Doi, H.; Tsuji, Y.; Miyamoto, T. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn. J. Cancer Res. 1985, 76, 474-480.
261. Ando, Y.; Nakano, S.; Saito, K.; Shimamoto, I.; Ichijo, M.; Toyama, T.; Hinuma, Y. Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: Comparison of bottle- with breast-fed babies. Jpn. J. Cancer Res. 1987, 78, 322-324.
262. Kusuhara, K.; Sonoda, S.; Takahashi, K.; Tokugawa, K.; Fukushige, J.; Ueda, K. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): A fifteen-year follow-up study in Okinawa, Japan. Int. J. Cancer 1987, 40, 755-757.
263. Kinoshita, K.; Hino, S.; Amagaski, T.; Ikeda, S.; Yamada, Y.; Suzuyama, J.; Momita, S.; Toriya, K.; Kamihira, S.; Ichimaru, M. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gann 1984, 75, 103-105.
264. Takeuchi, H.; Takahashi, M.; Norose, Y.; Takeshita, T.; Fukunaga, Y.; Takahashi, H. Transformation of breast milk macrophages by HTLV-I: Implications for HTLV-I transmission via breastfeeding. Biomed. Res. 2010, 31, 53-61.
265. Takahashi, K.; Takezaki, T.; Oki, T.; Kawakami, K.; Yashiki, S.; Fujiyoshi, T.; Usuku, K.; Mueller, N.; Osame, M.; Miyata, K., et al. Inhibitory effect of maternal antibody on mother-tochild transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group. Int. J. Cancer 1991, 49, 673-677.
266. Takezaki, T.; Tajima, K.; Ito, M.; Ito, S.; Kinoshita, K.; Tachibana, K.; Matsushita, Y., Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia 1997, 11, 60-62.
267. Wiktor, S.Z.; Pate, E.J.; Rosenberg, P.S.; Barnett, M.; Palmer, P.; Medeiros, D.; Maloney, E. M.; Blattner, W.A., Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J. Hum. Virol. 1997, 1, 37-44.
268. Ando, Y.; Nakano, S.; Saito, K.; Shimamoto, I.; Ichijo, M.; Toyama, T.; Hinuma, Y. Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process. Jpn. J. Cancer Res. 1986, 77, 974-977.
269. Ando, Y.; Kakimoto, K.; Tanigawa, T.; Furuki, K.; Saito, K.; Nakano, S.; Hashimoto, H.; Moriyama, I.; Ichijo, M.; Toyama, T. Effect of freeze-thawing breast milk on vertical HTLV-I transmission from seropositive mothers to children. Jpn. J. Cancer Res. 1989, 80, 405-407.
270. Yamato, K.; Taguchi, H.; Yoshimoto, S.; Fujishita, M.; Yamashita, M.; Ohtsuki, Y.; Hoshino, H.; Miyoshi, I. Inactivation of lymphocyte-transforming activity of human T-cell leukemia virus type I by heat. Jpn. J. Cancer Res. 1986, 77, 13-15.
271. Saito, S.; Furuki, K.; Ando, Y.; Tanigawa, T.; Kakimoto, K.; Moriyama, I.; Ichijo, M. Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction. Jpn. J. Cancer Res. 1990, 81,890-895.
272. Tajima, K.; Tominaga, S.; Suchi, T.; Kawagoe, T.; Komoda, H.; Hinuma, Y.; Oda, T.; Fujita, K. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: Possible horizontal transmission of adult T-cell leukemia virus. Gann 1982, 73, 893-901.
273. Kajiyama, W.; Kashiwagi, S.; Ikematsu, H.; Hayashi, J.; Nomura, H.; Okochi, K. Intrafamilial transmission of adult T cell leukemia virus. J. Infect. Dis. 1986, 154, 851-857.
274. Murphy, E.L.; Figueroa, J.P.; Gibbs, W.N.; Brathwaite, A.; Holding-Cobham, M.; Waters, D.; Cranston, B.; Hanchard, B.; Blattner, W.A. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med. 1989, 111, 555-560.
275. Stuver, S.O.; Tachibana, N.; Okayama, A.; Shioiri, S.; Tsunetoshi, Y.; Tsuda, K.; Mueller, N. E. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J. Infect. Dis. 1993, 167, 57-65.
276. Okochi, K.; Sato, H.; Hinuma, Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1984, 46, 245-253.
277. Sato, H.; Okochi, K. Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: demonstration of proviral DNA in recipients' blood lymphocytes. Int. J. Cancer 1986, 37, 395-400.
278. Larson, C.J.; Taswell, H.F. Human T-cell leukemia virus type I (HTLV-I) and blood transfusion. Mayo Clin. Proc. 1988, 63, 869-875.
279. Lee, H.; Swanson, P.; Shorty, V.S.; Zack, J.A.; Rosenblatt, J.D.; Chen, I.S. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science 1989, 244, 471-475.
280. Kwok, S.; Gallo, D.; Hanson, C.; McKinney, N.; Poiesz, B.; Sninsky, J.J. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res. Hum. Retroviruses 1990, 6, 561-565.
281. Zella, D.; Mori, L.; Sala, M.; Ferrante, P.; Casoli, C.; Magnani, G.; Achilli, G.; Cattaneo, E.; Lori, F.; Bertazzoni, U. HTLV-II infection in Italian drug abusers. Lancet 1990, 336, 575-576.
282. Khabbaz, R.F.; Hartel, D.; Lairmore, M.; Horsburgh, C.R.; Schoenbaum, E.E.; Roberts, B.; Hartley, T.M.; Friedland, G. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: An old infection? J. Infect. Dis. 1991, 163, 252-256.
283. Pepin, J.; Labbe, A.C.; Mamadou-Yaya, F.; Mbelesso, P.; Mbadingai, S.; Deslandes, S.; Locas, M.C.; Frost, E. Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa. Clin. Infect. Dis. 2010, 51, 777-784.
284. Morikawa, K.; Kuroda, M.; Tofuku, Y.; Uehara, H.; Akizawa, T.; Kitaoka, T.; Koshikawa, S.; Sugimoto, H.; Hashimoto, K. Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan. Am. J. Kidney Dis. 1988, 12, 185-193.
285. Kauffman, H.M.; Taranto, S.E. Human T-cell lymphotrophic virus type-1 and organ donors. Transplantation 2003, 76, 745-746.
286. González-Pérez, M.P.; Munoz-Juárez, L.; Cárdenas, F.C.; Zarranz Imirizaldu, J.J.; Carranceja, J.C.; García-Saiz, A. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 2003, 75, 1006-1011.
287. Zarranz Imirizaldu, J.J.; Gomez Esteban, J.C.; Rouco Axpe, I.; Perez Concha, T.; Velasco Juanes, F.; Allue Susaeta, I.; Corral Carranceja, J.M. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J. Neurol. Neurosurg. Psychiatry 2003, 74, 1080-1084.
288. Arjmand, B.; Aghayan, S.H.; Goodarzi, P.; Farzanehkhah, M.; Mortazavi, S.M.; Niknam, M.H.; Jafarian, A.; Arjmand, F.; Jebellyfar, S. Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank. Cell Tissue Bank 2009, 10, 247-252.
289. Khameneh, Z.R.; Sepehrvand, N.; Masudi, S.; Taghizade-Afshari, A. Seroprevalence of HTLV-1 among kidney graft recipients: A single-center study. Exp. Clin. Transplant. 2010, 8, 146-149.
290. Clark, J.; Saxinger, C.; Gibbs, W.N.; Lofters, W.; Lagranade, L.; Deceulaer, K.; Ensroth, A.; Robert-Guroff, M.; Gallo, R.C.; Blattner, W.A. Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. Int. J. Cancer 1985, 36, 37-41.
291. de The, G.; Gessain, A. Seroepidemiologic data on viral infections (HTLV-I and LAV/HTLV-III) in the Caribbean region and intertropical Africa. Ann. Pathol. 1986, 6, 261-264.
292. Iwanaga, M.; Chiyoda, S.; Kusaba, E.; Kamihira, S. Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006. Int. J. Hematol. 2009, 90, 186-190.
293. Galvao-Castro, B.; Loures, L.; Rodriques, L.G.; Sereno, A.; Ferreira Junior, O.C.; Franco, L.G.; Muller, M.; Sampaio, D.A.; Santana, A.; Passos, L.M., et al. Distribution of human T-lymphotropic virus type I among blood donors: A nationwide Brazilian study. Transfusion 1997, 37, 242-243.
294. Kazanji, M.; Gessain, A. Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: Clinical and molecular epidemiology. Cad. Saude Publica 2003, 19, 1227-1240.
295. Leon, G.; Quiros, A.M.; Lopez, J.L.; Hung, M.; Diaz, A.M.; Goncalves, J.; Da Costa, O.; Hernandez, T.; Chirinos, M.; Gomez, R. Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors. Rev. Panam. Salud Publica 2003, 13, 117-123.
296. Sanchez-Palacios, C.; Gotuzzo, E.; Vandamme, A.M.; Maldonado, Y. Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women. Int. J. Infect. Dis. 2003, 7, 132-137.
297. Gastaldello, R.; Hall, W.W.; Gallego, S. Seroepidemiology of HTLV-I/II in Argentina: an overview. J. Acquir. Immune Defic. Syndr. 2004, 35, 301-308.
298. Biglione, M.M.; Astarloa, L.; Salomon, H.E. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: A South American health concern. AIDS Res. Hum. Retroviruses 2005, 21, 1-4.
299. Chandia, L.; Sotomayor, C.; Ordenes, S.; Salas, P.; Navarrete, M.; Lopez, M.; Otth, C. Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile. Med. Microbiol. Immunol. 2010, 199, 341-344.
300. Osame, M.; Janssen, R.; Kubota, H.; Nishitani, H.; Igata, A.; Nagataki, S.; Mori, M.; Goto, I.; Shimabukuro, H.; Khabbaz, R., et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann. Neurol. 1990, 28, 50-56.
301. Inaba, S.; Okochi, K.; Sato, H.; Fukada, K.; Kinukawa, N.; Nakata, H.; Kinjyo, K.; Fujii, F.; Maeda, Y. Efficacy of donor screening for HTLV-I and the natural history of transfusiontransmitted infection. Transfusion 1999, 39, 1104-1110.
302. Polizzotto, M.N.; Wood, E.M.; Ingham, H.; Keller, A.J. Reducing the risk of ransfusiontransmissible viral infection through blood donor selection: The Australian experience 2000 through 2006. Transfusion 2008, 48, 55-63.
303. Berini, C.A.; Gendler, S.A.; Pascuccio, S.; Eirin, M.E.; McFarland, W.; Page, K.; Carnevali, L.; Murphy, E.; Biglione, M.M. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J. Med. Virol. 2010, 82, 873-877.
304. Lima, G.M.; Eustaquio, J.M.; Martins, R.A.; Josahkian, J.A.; Pereira Gde, A.; Moraes-Souza, H.; Martins, P.R. Decline in the prevalence of HTLV-1/2 among blood donors at the Regional Blood Center of the City of Uberaba, State of Minas Gerais, from 1995 to 2008. Rev. Soc. Bras. Med. Trop. 2010, 43, 421-424.
305. Bitar, N.; Hajj, H.E.; Houmani, Z.; Sabbah, A.; Otrock, Z.K.; Mahfouz, R.; Zaatari, G.; Bazarbachi, A. Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon. Transfusion 2009, 49, 1859-1864.
306. Stienlauf, S.; Yahalom, V.; Schwartz, E.; Shinar, E.; Segal, G.; Sidi, Y. Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel. Emerg. Infect. Dis. 2009, 15, 1116-1118.
307. de The, G.; Bomford, R. An HTLV-I vaccine: Why, how, for whom? AIDS Res. Hum. Retroviruses 1993, 9, 381-386.
308. Bomford, R.; Kazanji, M.; De The, G. Vaccine against human T cell leukemia-lymphoma virus type I: progress and prospects. AIDS Res. Hum. Retroviruses 1996, 12, 403-405.
309. Takehara, N.; Iwahara, Y.; Uemura, Y.; Sawada, T.; Ohtsuki, Y.; Iwai, H.; Hoshino, H.; Miyoshi, I. Effect of immunization on HTLV-I infection in rabbits. Int. J. Cancer 1989, 44, 332-336.
310. Nakamura, H.; Hayami, M.; Ohta, Y.; Ishikawa, K.; Tsujimoto, H.; Kiyokawa, T.; Yoshida, M.; Sasagawa, A.; Honjo, S. Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli. Int. J. Cancer 1987, 40, 403-407.
311. Ohashi, T.; Hanabuchi, S.; Kato, H.; Tateno, H.; Takemura, F.; Tsukahara, T.; Koya, Y.; Hasegawa, A.; Masuda, T.; Kannagi, M. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine. J. Virol. 2000, 74, 9610-9616.
312. Kazanji, M.; Tartaglia, J.; Franchini, G.; de Thoisy, B.; Talarmin, A.; Contamin, H.; Gessain, A.; de The, G. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus). J. Virol. 2001, 75, 5939-5948.
313. Baba, E.; Nakamura, M.; Ohkuma, K.; Kira, J.; Tanaka, Y.; Nakano, S.; Niho, Y. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 1995, 154, 399-412.
314. Tanaka, Y.; Tanaka, R.; Terada, E.; Koyanagi, Y.; Miyano-Kurosaki, N.; Yamamoto, N.; Baba, E.; Nakamura, M.; Shida, H. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 1994, 68, 6323-6331.
315. Hanabuchi, S.; Ohashi, T.; Koya, Y.; Kato, H.; Hasegawa, A.; Takemura, F.; Masuda, T.; Kannagi, M. Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity. J. Natl. Cancer Inst. 2001, 93, 1775-1783.
316. Sundaram, R.; Lynch, M.P.; Rawale, S.; Dakappagari, N.; Young, D.; Walker, C.M.; Lemonnier, F.; Jacobson, S.; Kaumaya, P.T. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus. J. Acquir. Immune Defic. Syndr. 2004, 37, 1329-1339.
317. Sundaram, R.; Sun, Y.; Walker, C.M.; Lemonnier, F.A.; Jacobson, S.; Kaumaya, P.T. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLAA* 0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine 2003, 21, 2767-2781.
318. Kobayashi, H.; Ngato, T.; Sato, K.; Aoki, N.; Kimura, S.; Tanaka, Y.; Aizawa, H.; Tateno, M.; Celis, E. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1- specific CD4+ helper T lymphocytes. Clin. Cancer Res. 2006, 12, 3814-3822.
319. Kozako, T.; Hirata, S.; Shimizu, Y.; Satoh, Y.; Yoshimitsu, M.; White, Y.; Lemonnier, F.; Shimeno, H.; Soeda, S.; Arima, N. Oligomannose-coated liposomes efficiently induce human Tcell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS J. 2011, 278, 1358-1366.
320. Kozako, T.; Fukada, K.; Hirata, S.; White, Y.; Harao, M.; Nishimura, Y.; Kino, Y.; Soeda, S.; Shimeno, H.; Lemonnier, F.; Sonoda, S.; Arima, N. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia. Mol. Immunol. 2009, 47, 606-613.
321. Conrad, S.F.; Byeon, I.J.; DiGeorge, A.M.; Lairmore, M.D.; Tsai, M.D.; Kaumaya, P.T. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I). Biomed. Pept. Proteins Nucleic Acids 1995, 1, 83-92.
322. Frangione-Beebe, M.; Albrecht, B.; Dakappagari, N.; Rose, R.T.; Brooks, C.L.; Schwendeman, S.P.; Lairmore, M.D.; Kaumaya, P.T. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide. Vaccine 2000, 19, 1068-1081.
323. Kazanji, M.; Heraud, J.M.; Merien, F.; Pique, C.; de The, G.; Gessain, A.; Jacobson, S. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized quirrel monkeys (Saimiri sciureus). J. Gen. Virol. 2006, 87, 1331-1337.
324. Shida, H.; Tochikura, T.; Sato, T.; Konno, T.; Hirayoshi, K.; Seki, M.; Ito, Y.; Hatanaka, M.; Hinuma, Y.; Sugimoto, M., et al. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J. 1987, 6, 3379-3384.
325. Hakoda, E.; Machida, H.; Tanaka, Y.; Morishita, N.; Sawada, T.; Shida, H.; Hoshino, H.; Miyoshi, I. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int. J. Cancer 1995, 60, 567-570.
326. Franchini, G.; Benson, J.; Gallo, R.; Paoletti, E.; Tartaglia, J. Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I. AIDS Res. Hum. Retroviruses 1996, 12, 407-408.
327. Franchini, G.; Tartaglia, J.; Markham, P.; Benson, J.; Fullen, J.; Wills, M.; Arp, J.; Dekaban, G.; Paoletti, E.; Gallo, R.C. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits. AIDS Res. Hum. Retroviruses 1995, 11, 307-313.
328. Ibuki, K.; Funahashi, S.I.; Yamamoto, H.; Nakamura, M.; Igarashi, T.; Miura, T.; Ido, E.; Hayami, M.; Shida, H. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J. Gen. Virol. 1997, 78, 147-152.
329. Kazanji, M.; Bomford, R.; Bessereau, J.L.; Schulz, T.; de The, G. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene. Int. J. Cancer 1997, 71, 300-307.
330. Kchour, G.; Makhoul, N.J.; Mahmoudi, M.; Kooshyar, M.M.; Shirdel, A.; Rastin, M.; Rafatpanah, H.; Tarhini, M.; Zalloua, P.A.; Hermine, O.; Farid, R.; Bazarbachi, A. Zidovudine and interferonalpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran. Leuk. Lymphoma 2007, 48, 330-336.
331. Tsukasaki, K.; Hermine, O.; Bazarbachi, A.; Ratner, L.; Ramos, J.C.; Harrington, W., Jr.; O'Mahony, D.; Janik, J.E.; Bittencourt, A.L.; Taylor, G.P., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J. Clin. Oncol. 2009, 27, 453-459.